All four pancreatic ductal adenocarcinomas with MMR deficiency in our study exhibited protein loss of MSH6, which was accompanied by protein loss of MSH2 in three cancers and was isolated in one cancer. Here, MSH2 is linked to pancreatic ductal adenocarcinoma.